Review
doi: 10.1093/bmb/ldl013.
Epub 2006 Dec 14.
Positron emission tomography in oncology
Affiliations
- PMID: 17169969
- DOI: 10.1093/bmb/ldl013
Item in Clipboard
Review
Positron emission tomography in oncology
Br Med Bull.
2006.
Abstract
Increasing access to positron emission tomography-computed tomography (PET-CT) has resulted in a shift towards functional imaging, being the primary tool in the assessment of viable tumour in oncology patients. In this review, we discuss the basic principles of this evolving technology and the radio-isotopes it employs. The main clinical applications of PET-CT are reviewed and some of the limitations of the technique are highlighted. Finally, we offer insight into possible future developments and how these modify current practice.
Similar articles
-
PET/CT in oncology--a major advance.Clin Radiol. 2005 Nov;60(11):1143-55. doi: 10.1016/j.crad.2005.05.018. Clin Radiol. 2005. PMID: 16223611 Review.
-
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.Semin Nucl Med. 2007 Nov;37(6):400-19. doi: 10.1053/j.semnuclmed.2007.08.004. Semin Nucl Med. 2007. PMID: 17920348 Review.
-
Standardization and quantification in PET/CT imaging: tracers beyond FDG.PET Clin. 2014 Jul;9(3):259-66. doi: 10.1016/j.cpet.2014.03.002. Epub 2014 May 6. PET Clin. 2014. PMID: 25030389 Review.
-
[The contribution of PET to radiation treatment planning].Bull Cancer. 2007 Jan;94(1):99-108. Bull Cancer. 2007. PMID: 17237010 Review. French.
-
FDG PET and PET/CT.Recent Results Cancer Res. 2013;187:351-69. doi: 10.1007/978-3-642-10853-2_12. Recent Results Cancer Res. 2013. PMID: 23179888 Review.
Cited by
-
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.Nucl Med Biol. 2020 Jul-Aug;86-87:20-29. doi: 10.1016/j.nucmedbio.2020.03.006. Epub 2020 Apr 3. Nucl Med Biol. 2020. PMID: 32447069 Free PMC article.
-
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review.Int J Mol Sci. 2023 Feb 15;24(4):3863. doi: 10.3390/ijms24043863. Int J Mol Sci. 2023. PMID: 36835275 Free PMC article.
-
PET/CT-Guided Interventions in Oncology Patients: A Nursing Perspective.J Radiol Nurs. 2017 Jun;36(2):99-103. doi: 10.1016/j.jradnu.2016.10.014. Epub 2017 May 20. J Radiol Nurs. 2017. PMID: 29398985 Free PMC article.
-
Advances in Clinical Oncology Research on 99mTc-3PRGD2 SPECT Imaging.Front Oncol. 2022 May 31;12:898764. doi: 10.3389/fonc.2022.898764. eCollection 2022. Front Oncol. 2022. PMID: 35712468 Free PMC article. Review.
-
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene.Oncotarget. 2013 Apr;4(4):584-99. doi: 10.18632/oncotarget.965. Oncotarget. 2013. PMID: 23603840 Free PMC article.
